Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Photothermal therapy technology of metastatic colorectal cancer.
Chen J, Zeng Z, Huang L, Luo S, Dong J, Zhou FH, Zhou K, Wang L, Kang L. Chen J, et al. Among authors: luo s. Am J Transl Res. 2020 Jul 15;12(7):3089-3115. eCollection 2020. Am J Transl Res. 2020. PMID: 32774688 Free PMC article. Review.
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial.
Hu H, Kang L, Zhang J, Wu Z, Wang H, Huang M, Lan P, Wu X, Wang C, Cao W, Hu J, Huang Y, Huang L, Wang H, Shi L, Cai Y, Shen C, Ling J, Xie X, Cai Y, He X, Dou R, Zhou J, Ma T, Zhang X, Luo S, Deng W, Ling L, Liu H, Deng Y. Hu H, et al. Among authors: luo s. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):38-48. doi: 10.1016/S2468-1253(21)00348-4. Epub 2021 Oct 22. Lancet Gastroenterol Hepatol. 2022. PMID: 34688374 Clinical Trial.
Clinical significance of neoadjuvant chemotherapy for locally advanced colorectal cancer patients with deficient mismatch repair: possibly residual value in the era of immunotherapy.
Chen M, Chen J, Huang J, Liu H, Cao W, Luo S, Liu Z, Hu H, Lai S, Hou Y, Kang L, Huang L. Chen M, et al. Among authors: luo s. Therap Adv Gastroenterol. 2023 Jan 19;16:17562848221150306. doi: 10.1177/17562848221150306. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 36742014 Free PMC article.
Effects of tumour budding on adjuvant chemotherapy in colorectal cancer.
Xie H, Zeng Z, Hou Y, Ye F, Cai T, Cai Y, Xiong L, Li W, Liu Z, Liang Z, Luo S, Zheng X, Huang L, Liu H, Kang L. Xie H, et al. Among authors: luo s. BJS Open. 2024 Jan 3;8(1):zrad115. doi: 10.1093/bjsopen/zrad115. BJS Open. 2024. PMID: 38190579 Free PMC article.
Transanal total mesorectal excision combined with intersphincteric resection has similar long-term oncological outcomes to laparoscopic abdominoperineal resection in low rectal cancer: a propensity score-matched cohort study.
Liu ZH, Zeng ZW, Jie HQ, Huang L, Luo SL, Liang WF, Zhang XW, Kang L. Liu ZH, et al. Gastroenterol Rep (Oxf). 2022 Jun 14;10:goac026. doi: 10.1093/gastro/goac026. eCollection 2022. Gastroenterol Rep (Oxf). 2022. PMID: 35711716 Free PMC article.
Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study.
Li K, Zhao F, Guo Y, Wu Q, Luo S, Zhang J, Li H, Hu S, Wu B, Lin G, Qiu H, Niu B, Sun X, Xu L, Lu J, Du X, Wang Z, Wang X, Kang L, Wang Z, Wang Q, Liu Q, Xiao Y. Li K, et al. Among authors: luo s. BMC Cancer. 2023 Sep 18;23(1):797. doi: 10.1186/s12885-023-11196-4. BMC Cancer. 2023. PMID: 37718392 Free PMC article.
9,525 results